Life insurance after cancer depends on what you had, how it was treated, and how long you have been in remission. Carriers do not treat all cancer histories the same—a basal cell skin cancer removed five years ago is a different underwriting conversation than Stage III breast cancer two years post-treatment. The American Cancer Society reports millions of cancer survivors in the U.S., and the life insurance market has developed specific remission timelines and rate classes for the most common diagnoses.
At Local Life Agents, we match cancer survivors to carriers whose post-remission guidelines fit your specific diagnosis and timeline—before a formal application creates an MIB record.
Key Takeaways
- Remission time is critical. Most carriers want two to five years cancer-free after treatment ends before offering standard rates; some aggressive cancers require ten years.
- Cancer type matters. Skin cancers (basal cell, squamous cell) are often standard rates immediately after removal; blood cancers and metastatic disease have longer waiting periods.
- Stage and grade at diagnosis drive the timeline—Stage I localized cancers clear faster than Stage III or IV histories.
- Ongoing surveillance is expected. Regular oncology follow-up with clean scans strengthens your file; missed appointments raise flags.
- Active cancer usually means decline at fully underwritten carriers—focus on simplified issue or guaranteed issue until remission is established.
Compare cancer survivor life insurance rates
Compare cancer survivor rates across carriers whose post-remission guidelines match your specific diagnosis and timeline.
What do underwriters look for with a cancer history?
Underwriters assess recurrence risk based on your specific diagnosis and how long you have been clear. They will request attending physician statements from your oncologist for most cancer histories.
- Cancer type and location — Thyroid, testicular, and many skin cancers have shorter waiting periods; lung, pancreatic, and metastatic cancers have the longest or may be uninsurable at standard carriers.
- Stage and grade at diagnosis — Stage I localized disease clears underwriting faster than regional spread or lymph node involvement.
- Treatment completed — Surgery alone, radiation, chemotherapy, or combination therapy each carry different follow-up expectations.
- Time since treatment ended — Not time since diagnosis—time since last treatment. Carriers count from the end of active therapy.
- Current status — Remission with clean surveillance scans vs. active disease or rising tumor markers.
- Recurrence history — A second primary cancer or recurrence resets the clock and significantly worsens offers.
Have your oncology records organized: pathology report, treatment summary, and most recent follow-up note with your oncologist's assessment of remission status.
Application questions you'll see:
- What type of cancer were you diagnosed with, and when?
- What stage and grade was the cancer at diagnosis?
- What treatment did you receive (surgery, radiation, chemotherapy, combination)?
- When did your treatment end?
- What is your current cancer status (remission, surveillance, active disease)?
- When was your last oncology follow-up visit, and what were the results?
- Have you had any recurrence or new cancer diagnosis?
How does a cancer history affect your rate class?
Non-melanoma skin cancer (basal cell, squamous cell) removed with clean margins often qualifies for Preferred or Standard immediately—some carriers do not rate it at all after excision.
Common solid tumors—breast, prostate, colon, thyroid—in Stage I or II with two to five years remission often land Standard at carriers with favorable oncology guidelines. Some carriers add a flat extra per thousand dollars of coverage for the first few years after the waiting period clears.
Blood cancers (leukemia, lymphoma) and Stage III or IV histories typically require five to ten years remission before Standard is available; shorter timelines mean table ratings or decline. Active cancer, ongoing chemotherapy, or hospice care means decline at fully underwritten carriers.
If standard underwriting is not available yet, simplified-issue products with health questions (not guaranteed issue) may work for early remission, and guaranteed issue life insurance remains the fallback when health has closed other doors.
Can you get standard rates after cancer?
Standard rates are possible for many cancer survivors—it depends on cancer type, stage, and time in remission. Non-melanoma skin cancers often qualify immediately after removal. Common solid tumors (breast, prostate, thyroid, colon) in early stages typically reach Standard rates two to five years post-treatment. Blood cancers and advanced-stage histories usually require longer waiting periods, often five to ten years. The carrier match matters as much as the timeline—different companies have different post-remission guidelines for the same diagnosis.
Which carriers handle cancer survivors most competitively?
Oncology underwriting varies significantly. Lincoln, Prudential, and John Hancock have historically been workable for common solid tumors past the standard waiting period. Principal has been competitive for certain thyroid and testicular cancer histories. Blood cancer survivors often need impaired-risk specialists or carriers with dedicated table-rating programs.
The wrong approach is applying to whichever carrier you have heard of first. A formal decline or heavy table rating from one company creates MIB codes that the next underwriter sees before reading your file. Pre-screening with an independent agent—sending your oncology summary informally to carriers known to be favorable for your cancer type—changes the outcome.
Expert Tip: Count from treatment end, not diagnosis
Survivors often tell me they have been cancer-free for four years when they mean four years since diagnosis—but they finished chemo only two years ago. Underwriters start the clock at the end of active treatment. Get your oncology records straight before you apply, or you will waste time with carriers whose guidelines you have not actually met yet.
—Ryan Wood
Conclusion
Cancer survivors can get life insurance—the question is which carrier, which waiting period, and which rate class fits your specific history. That matching problem is exactly what independent agents solve: we shop 30+ A-rated carriers, pre-screen oncology files informally, and submit where your remission timeline and cancer type align with published guidelines. Applying blind after cancer costs money and creates application records that follow you.
If you are past the standard waiting period with clean follow-up, shopping can mean the difference between Standard and a table rating—or between coverage and an unnecessary decline. If you are still within the waiting period, we can map when to reapply and what products bridge the gap until standard underwriting opens. Return to our life insurance hub for product guides and coverage types.
Life Insurance
See what you'd pay — run your numbers across 30+ A-rated carriers in about 2 minutes.
Run My Numbers